Bumper Offer - Urjas oil Just @ Rs. 1
StayHappi Telmisartan + Chlorthalidone Tablet is an allopathic medicine The correct dosage of StayHappi Telmisartan + Chlorthalidone Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
StayHappi Telmisartan + Chlorthalidone Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when StayHappi Telmisartan + Chlorthalidone Tablet is used -
Severe
Mild
Common
Is the use of StayHappi Telmisartan + Chlorthalidone Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking StayHappi Telmisartan + Chlorthalidone Tablet. If you are pregnant, do not take StayHappi Telmisartan + Chlorthalidone Tablet without a doctor's advice.
Is the use of StayHappi Telmisartan + Chlorthalidone Tablet safe during breastfeeding?
StayHappi Telmisartan + Chlorthalidone Tablet has been seen to have minimal side effects on breastfeeding women.
What is the effect of StayHappi Telmisartan + Chlorthalidone Tablet on the Kidneys?
There are no side effects of StayHappi Telmisartan + Chlorthalidone Tablet on the kidneys.
What is the effect of StayHappi Telmisartan + Chlorthalidone Tablet on the Liver?
StayHappi Telmisartan + Chlorthalidone Tablet has very mild side effects on the liver.
What is the effect of StayHappi Telmisartan + Chlorthalidone Tablet on the Heart?
StayHappi Telmisartan + Chlorthalidone Tablet is rarely harmful for the heart.
StayHappi Telmisartan + Chlorthalidone Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take StayHappi Telmisartan + Chlorthalidone Tablet unless your doctor advises you to do so -
Is this StayHappi Telmisartan + Chlorthalidone Tablet habit forming or addictive?
Forming a habit of StayHappi Telmisartan + Chlorthalidone Tablet has not been reported.
Interaction between Food and StayHappi Telmisartan + Chlorthalidone Tablet
Taking StayHappi Telmisartan + Chlorthalidone Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and StayHappi Telmisartan + Chlorthalidone Tablet
Taking StayHappi Telmisartan + Chlorthalidone Tablet with alcohol can have severely harmful effects on your health.
Yes, you may take StayHappi Telmisartan + Chlorthalidone Tablet with metoprolol as it will help in reducing high blood pressure and slow the heart rate. But using this combination may cause some side effects like dizziness, weakness, fainting, fast or irregular heartbeats, or loss of blood glucose control. If you experience any of these side effects then consult it with your doctor immediately.
Yes, StayHappi Telmisartan + Chlorthalidone Tablet can be taken at night but you are advised to take it in the morning to avoid sleep disturbances caused by excessive urination during the night.
Yes, StayHappi Telmisartan + Chlorthalidone Tablet is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as diarrhea, headache, and dizziness. If you experience any discomfort after taking this do inform your doctor.
StayHappi Telmisartan + Chlorthalidone Tablet is a brand name of chlorthalidone and it is available in the form of tablets. It belongs to the class of drugs known as thiazide diuretics. StayHappi Telmisartan + Chlorthalidone Tablet is a prescription drug that is used in hypertension (high blood pressure) and reduces swelling of liver and kidney due to excess accumulation of fluid.
Yes, StayHappi Telmisartan + Chlorthalidone Tablet may cause itching or rashes but it occurs rarely. If you experience excessive rashes or itching then consult it with your doctor without any further delay.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
